166 related articles for article (PubMed ID: 35766235)
21. Disease model organism for Parkinson disease: Drosophila melanogaster.
Aryal B; Lee Y
BMB Rep; 2019 Apr; 52(4):250-258. PubMed ID: 30545438
[TBL] [Abstract][Full Text] [Related]
22. The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease.
Sharma N; Rao SP; Kalivendi SV
Free Radic Biol Med; 2019 May; 135():28-37. PubMed ID: 30796974
[TBL] [Abstract][Full Text] [Related]
23. Roles of Drosophila DJ-1 in survival of dopaminergic neurons and oxidative stress.
Menzies FM; Yenisetti SC; Min KT
Curr Biol; 2005 Sep; 15(17):1578-82. PubMed ID: 16139214
[TBL] [Abstract][Full Text] [Related]
24. Antidiabetic drugs for Alzheimer's and Parkinson's diseases: Repurposing insulin, metformin, and thiazolidinediones.
Cardoso S; Moreira PI
Int Rev Neurobiol; 2020; 155():37-64. PubMed ID: 32854858
[TBL] [Abstract][Full Text] [Related]
25. Mutational analysis of DJ-1 in Drosophila implicates functional inactivation by oxidative damage and aging.
Meulener MC; Xu K; Thomson L; Ischiropoulos H; Bonini NM
Proc Natl Acad Sci U S A; 2006 Aug; 103(33):12517-22. PubMed ID: 16894167
[TBL] [Abstract][Full Text] [Related]
26. DJ-1-binding compounds prevent oxidative stress-induced cell death and movement defect in Parkinson's disease model rats.
Miyazaki S; Yanagida T; Nunome K; Ishikawa S; Inden M; Kitamura Y; Nakagawa S; Taira T; Hirota K; Niwa M; Iguchi-Ariga SM; Ariga H
J Neurochem; 2008 Jun; 105(6):2418-34. PubMed ID: 18373560
[TBL] [Abstract][Full Text] [Related]
27. Circadian Rhythm Abnormalities in Parkinson's Disease from Humans to Flies and Back.
De Lazzari F; Bisaglia M; Zordan MA; Sandrelli F
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30563246
[TBL] [Abstract][Full Text] [Related]
28. Isocitrate protects DJ-1 null dopaminergic cells from oxidative stress through NADP+-dependent isocitrate dehydrogenase (IDH).
Yang J; Kim MJ; Yoon W; Kim EY; Kim H; Lee Y; Min B; Kang KS; Son JH; Park HT; Chung J; Koh H
PLoS Genet; 2017 Aug; 13(8):e1006975. PubMed ID: 28827794
[TBL] [Abstract][Full Text] [Related]
29. Curcumin Effectively Rescued Parkinson's Disease-Like Phenotypes in a Novel
Nguyen TT; Vuu MD; Huynh MA; Yamaguchi M; Tran LT; Dang TPT
Oxid Med Cell Longev; 2018; 2018():2038267. PubMed ID: 30057672
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic Activities of DJ-1 and Its Binding Compounds Against Neurodegenerative Diseases.
Inden M; Yanagisawa D; Hijioka M; Ariga H; Kitamura Y
Adv Exp Med Biol; 2017; 1037():187-202. PubMed ID: 29147910
[TBL] [Abstract][Full Text] [Related]
31. Antioxidant compound supplementation prevents oxidative damage in a Drosophila model of Parkinson's disease.
Casani S; Gómez-Pastor R; Matallana E; Paricio N
Free Radic Biol Med; 2013 Aug; 61():151-60. PubMed ID: 23548634
[TBL] [Abstract][Full Text] [Related]
32. DJ-1 modulates the unfolded protein response and cell death via upregulation of ATF4 following ER stress.
Yang J; Kim KS; Iyirhiaro GO; Marcogliese PC; Callaghan SM; Qu D; Kim WJ; Slack RS; Park DS
Cell Death Dis; 2019 Feb; 10(2):135. PubMed ID: 30755590
[TBL] [Abstract][Full Text] [Related]
33. Role of DJ-1 in the mechanism of pathogenesis of Parkinson's disease.
Dolgacheva LP; Berezhnov AV; Fedotova EI; Zinchenko VP; Abramov AY
J Bioenerg Biomembr; 2019 Jun; 51(3):175-188. PubMed ID: 31054074
[TBL] [Abstract][Full Text] [Related]
34. Mitochondrial electron transport chain defects modify Parkinson's disease phenotypes in a Drosophila model.
O'Hanlon ME; Tweedy C; Scialo F; Bass R; Sanz A; Smulders-Srinivasan TK
Neurobiol Dis; 2022 Sep; 171():105803. PubMed ID: 35764292
[TBL] [Abstract][Full Text] [Related]
35. Type 2 Diabetes (T2DM) and Parkinson's Disease (PD): a Mechanistic Approach.
Sabari SS; Balasubramani K; Iyer M; Sureshbabu HW; Venkatesan D; Gopalakrishnan AV; Narayanaswamy A; Senthil Kumar N; Vellingiri B
Mol Neurobiol; 2023 Aug; 60(8):4547-4573. PubMed ID: 37118323
[TBL] [Abstract][Full Text] [Related]
36. Introduction/Overview.
Ariga H; Iguchi-Ariga SMM
Adv Exp Med Biol; 2017; 1037():1-4. PubMed ID: 29147899
[TBL] [Abstract][Full Text] [Related]
37. Age- and diet-dependent requirement of DJ-1 for glucose homeostasis in mice with implications for human type 2 diabetes.
Jain D; Jain R; Eberhard D; Eglinger J; Bugliani M; Piemonti L; Marchetti P; Lammert E
J Mol Cell Biol; 2012 Aug; 4(4):221-30. PubMed ID: 22611253
[TBL] [Abstract][Full Text] [Related]
38. PARK7/DJ-1 as a Therapeutic Target in Gut-Brain Axis Diseases.
Pap D; Veres-Székely A; Szebeni B; Vannay Á
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743072
[TBL] [Abstract][Full Text] [Related]
39. Protection against dopaminergic neurodegeneration in Parkinson's disease-model animals by a modulator of the oxidized form of DJ-1, a wild-type of familial Parkinson's disease-linked PARK7.
Inden M; Kitamura Y; Takahashi K; Takata K; Ito N; Niwa R; Funayama R; Nishimura K; Taniguchi T; Honda T; Taira T; Ariga H
J Pharmacol Sci; 2011; 117(3):189-203. PubMed ID: 22041943
[TBL] [Abstract][Full Text] [Related]
40. Pyruvate Dehydrogenase Kinase Protects Dopaminergic Neurons from Oxidative Stress in
Lee Y; Kim J; Kim H; Han JE; Kim S; Kang KH; Kim D; Kim JM; Koh H
Mol Cells; 2022 Jul; 45(7):454-464. PubMed ID: 35444068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
